Current knowledge of TNF-α monoclonal antibody infliximab in treating Kawasaki disease: a comprehensive review

Current knowledge of TNF-α monoclonal antibody infliximab in treating Kawasaki disease: a comprehensive review

Kawasaki disease (KD), an autoinflammatory disease primarily affecting young children, characterized by consisting of acute systemic vasculitis and coronary artery involvement in severe cases. Intravenous immunoglobulin gamma (IVIG) combined with aspirin therapy is the first-line regimen for the pre...

Full description

Bibliographic Details
Main Authors: Jiaying Chen, Jian Liao, Lupeng Xiang, Shilong Zhang, Yajing Yan
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Series:Frontiers in Immunology
Subjects:
Kawasaki disease
infliximab
treatment
adverse effect
TNF-α
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1237670/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1237670/full

Similar Items